Frontiers in Aging Neuroscience

Article	Citations
Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease	235
Microglia Polarization From M1 to M2 in Neurodegenerative Diseases	229
Machine Learning for the Diagnosis of Parkinson's Disease: A Review of Literature	154
Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD Study	140
Cellular Senescence in Brain Aging	129
Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia	123
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2019	117
The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis	115
Cholesterol and Alzheimer’s Disease; From Risk Genes to Pathological Effects	113
The Impact of Disease Comorbidities in Alzheimer's Disease	110
Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer’s Disease: A Focus on Aducanumab and Lecanemab	106
The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases	106
Mitochondrial Dysfunction and Alzheimer’s Disease: Role of Microglia	96
Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?	84
Functional Aging in Male C57BL/6J Mice Across the Life-Span: A Systematic Behavioral Analysis of Motor, Emotional, and Memory Function to Define an Aging Phenotype	82
Interleukin-17A: The Key Cytokine in Neurodegenerative Diseases	82
Astrocyte Senescence and Alzheimer’s Disease: A Review	81
APOE Alleles and Diet in Brain Aging and Alzheimer’s Disease	81
Mechanisms of Pathogenic Tau and Aβ Protein Spreading in Alzheimer’s Disease	79
The Impact of COVID-19 Quarantine on Patients With Dementia and Family Caregivers: A Nation-Wide Survey	77
Alzheimer’s Disease: An Update and Insights Into Pathophysiology	72
Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease	72
The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain	72
Neuroimmunomodulatory and Neuroprotective Effects of the Flavonoid Apigenin in in vitro Models of Neuroinflammation Associated With Alzheimer’s Disease	68
Mild Behavioral Impairment Is Associated With Atrophy of Entorhinal Cortex and Hippocampus in a Memory Clinic Cohort	65

The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review	64
The Role of Resting-State Network Functional Connectivity in Cognitive Aging	63
Age-Related Olfactory Dysfunction: Epidemiology, Pathophysiology, and Clinical Management	63
Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases	62
Inflammation From Peripheral Organs to the Brain: How Does Systemic Inflammation Cause Neuroinflammation?	60
Molecular Chaperones: A Double-Edged Sword in Neurodegenerative Diseases	60
Grip Strength and the Risk of Cognitive Decline and Dementia: A Systematic Review and Meta-Analysis of Longitudinal Cohort Studies	59
Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough	58
Prevalence of Alzheimer's Disease and Parkinson's Disease in China: An Updated Systematical Analysis	55
Mitophagy in Cerebral Ischemia and Ischemia/Reperfusion Injury	54
Gut Microbiome Signatures Are Biomarkers for Cognitive Impairment in Patients With Ischemic Stroke	53
Plant-Derived Antioxidants Protect the Nervous System From Aging by Inhibiting Oxidative Stress	53
Update on the Mechanism and Treatment of Sevoflurane-Induced Postoperative Cognitive Dysfunction	52
Past, Present, and Future of Non-invasive Brain Stimulation Approaches to Treat Cognitive Impairment in Neurodegenerative Diseases: Time for a Comprehensive Critical Review	52
Detection of Mild Cognitive Impairment Using Convolutional Neural Network: Temporal-Feature Maps of Functional Near-Infrared Spectroscopy	50
Nicotinamide, a Poly [ADP-Ribose] Polymerase 1 (PARP-1) Inhibitor, as an Adjunctive Therapy for the Treatment of Alzheimer’s Disease	50
Hearing Loss and Cognition: What We Know and Where We Need to Go	50
The Cross-Links of Endoplasmic Reticulum Stress, Autophagy, and Neurodegeneration in Parkinson’s Disease	50
Exploring Sex-Related Differences in Microglia May Be a Game-Changer in Precision Medicine	50
Microglia and Neuroinflammation: Crucial Pathological Mechanisms in Traumatic Brain Injury-Induced Neurodegeneration	50
COVCOG 2: Cognitive and Memory Deficits in Long COVID: A Second Publication From the COVID and Cognition Study	49
Heterogeneity in Regional Damage Detected by Neuroimaging and Neuropathological Studies in Older Adults With COVID-19: A Cognitive-Neuroscience Systematic Review to Inform the Long-Term Impact of the	49
Role of the Extracellular Matrix in Alzheimer’s Disease	47
Stem Cells of the Aging Brain	46
Diffusion Tensor Imaging Along the Perivascular Space Index in Different Stages of Parkinson’s Disease	46
Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications	46
Spotlight on Ferroptosis: Iron-Dependent Cell Death in Alzheimer’s Disease	46
Overview of Meta-Analyses of Five Non-pharmacological Interventions for Alzheimer's Disease	46
Clinical and Genetic Aspects of CADASIL	46
Normal Aging Induces Changes in the Brain and Neurodegeneration Progress: Review of the Structural, Biochemical, Metabolic, Cellular, and Molecular Changes	45
Prevention of Early Alzheimer’s Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study	45
Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target	45
Identifying Early Mild Cognitive Impairment by Multi-Modality MRI-Based Deep Learning	45
Dysfunction of the Blood-Brain Barrier—A Key Step in Neurodegeneration and Dementia	44
Iron Dyshomeostasis and Ferroptosis: A New Alzheimer’s Disease Hypothesis?	44
A Meta-Analysis of Brain DNA Methylation Across Sex, Age, and Alzheimer's Disease Points for Accelerated Epigenetic Aging in Neurodegeneration	43
Characterization of Age-Related Differences in the Human Choroid Plexus Volume, Microstructural Integrity, and Blood Perfusion Using Multiparameter Magnetic Resonance Imaging	43
Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer’s Disease: the Receptor for Advanced Glycation End Products (RAGE)	43
Effects of Virtual Reality Intervention on Cognition and Motor Function in Older Adults With Mild Cognitive Impairment or Dementia: A Systematic Review and Meta-Analysis	42
Multiple Roles in Neuroprotection for the Exercise Derived Myokine Irisin	42
Decreased Retinal Vascular Density in Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI): An Optical Coherence Tomography Angiography (OCTA) Study	42
Gait Progression Over 6 Years in Parkinson’s Disease: Effects of Age, Medication, and Pathology	42
RETRACTED: ADVIAN: Alzheimer's Disease VGG-Inspired Attention Network Based on Convolutional Block Attention Module and Multiple Way Data Augmentation	41
Endogenous and Exogenous Estrogen Exposures: How Women’s Reproductive Health Can Drive Brain Aging and Inform Alzheimer’s Prevention	41
Neurogranin: A Potential Biomarker of Neurological and Mental Diseases	40
Deep Brain Stimulation for Alzheimer's Disease: Stimulation Parameters and Potential Mechanisms of Action	40
The Role of Protein Persulfidation in Brain Aging and Neurodegeneration	40
PET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research	40
Comparing Pre-trained and Feature-Based Models for Prediction of Alzheimer's Disease Based on Speech	40
Novel STMN2 Variant Linked to Amyotrophic Lateral Sclerosis Risk and Clinical Phenotype	39

Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer’s Disease	39
The Unifying Hypothesis of Alzheimer’s Disease: Heparan Sulfate Proteoglycans/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago	39
Neuregulins in Neurodegenerative Diseases	39
The Glymphatic System: A Novel Therapeutic Target for Stroke Treatment	39
Cerebral Fructose Metabolism as a Potential Mechanism Driving Alzheimer’s Disease	38
Early Detection and Prevention of Alzheimer’s Disease: Role of Oxidative Markers and Natural Antioxidants	38
Chasing Protection in Parkinson’s Disease: Does Exercise Reduce Risk and Progression?	38
Dysfunction of the Glymphatic System Might Be Related to Iron Deposition in the Normal Aging Brain	38
Brain Ischemia as a Prelude to Alzheimer's Disease	38
The Emerging Role of the Interplay Among Astrocytes, Microglia, and Neurons in the Hippocampus in Health and Disease	37
Being the Family Caregiver of a Patient With Dementia During the Coronavirus Disease 2019 Lockdown	37
Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer’s Disease	37
Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis	37
Cognitive Reserve in Model Systems for Mechanistic Discovery: The Importance of Longitudinal Studies	37
The Eminent Role of microRNAs in the Pathogenesis of Alzheimer's Disease	37
Characterization of EEG Data Revealing Relationships With Cognitive and Motor Symptoms in Parkinson's Disease: A Systematic Review	36
Secreted Chaperones in Neurodegeneration	36
Mitochondrial Dysfunction in Parkinson’s Disease: From Mechanistic Insights to Therapy	36
Plasma and CSF Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: A Cross-Sectional and Longitudinal Study	36
Identification and immunological characterization of cuproptosis-related molecular clusters in Alzheimer's disease	36
The Mitochondrial Unfolded Protein Response: A Hinge Between Healthy and Pathological Aging	36
Enteric Nervous System: The Bridge Between the Gut Microbiota and Neurological Disorders	36
Genistein Attenuates Acute Cerebral Ischemic Damage by Inhibiting the NLRP3 Inflammasome in Reproductively Senescent Mice	36
Glymphatic Dysfunction in Patients With Ischemic Stroke	35
Effectiveness of an Innovative Cognitive Treatment and Telerehabilitation on Subjects With Mild Cognitive Impairment: A Multicenter, Randomized, Active-Controlled Study	35
Functional Metabolic Mapping Reveals Highly Active Branched-Chain Amino Acid Metabolism in Human Astrocytes, Which Is Impaired in iPSC-Derived Astrocytes in Alzheimer's Disease	35
Mitochondrial Behavior in Axon Degeneration and Regeneration	35
The Role of Microglia in Perioperative Neuroinflammation and Neurocognitive Disorders	35
Age-Related Changes in Pain Perception Are Associated With Altered Functional Connectivity During Resting State	35
Effectiveness and Safety of Acupuncture for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis	35
Graph Theory Analysis Reveals Resting-State Compensatory Mechanisms in Healthy Aging and Prodromal Alzheimer’s Disease	34
Dl-3-n-Butylphthalide Promotes Remyelination and Suppresses Inflammation by Regulating AMPK/SIRT1 and STAT3/NF-κB Signaling in Chronic Cerebral Hypoperfusion	34
Local Brain-Age: A U-Net Model	34
Anodal Transcranial Direct Current Stimulation Can Improve Spatial Learning and Memory and Attenuate Aβ42 Burden at the Early Stage of Alzheimer’s Disease in APP/PS1 Transgenic Mice	34
APP, PSEN1, and PSEN2 Variants in Alzheimer’s Disease: Systematic Re-evaluation According to ACMG Guidelines	34
Western Diet Induces Impairment of Liver-Brain Axis Accelerating Neuroinflammation and Amyloid Pathology in Alzheimer's Disease	34
From Neurodevelopmental to Neurodegenerative Disorders: The Vascular Continuum	33
Prevalence and Associated Risk Factors of Cognitive Frailty: A Systematic Review and Meta-Analysis	33
Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders	33
Intranasal Transplantation of Human Neural Stem Cells Ameliorates Alzheimer's Disease-Like Pathology in a Mouse Model	33
Progress of RAGE Molecular Imaging in Alzheimer’s Disease	33
Acoustic and Language Based Deep Learning Approaches for Alzheimer's Dementia Detection From Spontaneous Speech	33
Role of mTOR-Regulated Autophagy in Synaptic Plasticity Related Proteins Downregulation and the Reference Memory Deficits Induced by Anesthesia/Surgery in Aged Mice	33
Prevalence and Predictors of Prolonged Cognitive and Psychological Symptoms Following COVID-19 in the United States	32
Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform	32
Carbonic Anhydrases as Potential Targets Against Neurovascular Unit Dysfunction in Alzheimer’s Disease and Stroke	32
COVID-19-Related Intracerebral Hemorrhage	32
Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2*R47H	32
Propionate and Alzheimer’s Disease	32
Intracranial Atherosclerotic Plaque Characteristics and Burden Associated With Recurrent Acute Stroke: A 3D Quantitative Vessel Wall MRI Study	31
Dual-Task Exercise to Improve Cognition and Functional Capacity of Healthy Older Adults	31
Cholesterol, Atherosclerosis, and APOE in Vascular Contributions to Cognitive Impairment and Dementia (VCID): Potential Mechanisms and Therapy	31
Functional MRI-Specific Alterations in Executive Control Network in Mild Cognitive Impairment: An ALE Meta-Analysis	31
The Future of GDNF in Parkinson's Disease	31
Resilience and Psychobiological Response to Stress in Older People: The Mediating Role of Coping Strategies	31
Deep Convolutional Neural Networks With Ensemble Learning and Generative Adversarial Networks for Alzheimer’s Disease Image Data Classification	31
Age-Related Alterations in DTI Metrics in the Human Brain—Consequences for Age Correction	30
Identification of Circular RNA hsa_Circ_0003391 in Peripheral Blood Is Potentially Associated With Alzheimer's Disease	30
Probiotic Supplementation Facilitates Recovery of 6-OHDA-Induced Motor Deficit via Improving Mitochondrial Function and Energy Metabolism	30
Impact of COVID-19 Pandemic on Patients With Neurodegenerative Diseases	30
Multi-Targets: An Unconventional Drug Development Strategy for Alzheimer’s Disease	30
The Complexity of Microglial Interactions With Innate and Adaptive Immune Cells in Alzheimer’s Disease	30
The Association Between Glymphatic System Dysfunction and Cognitive Impairment in Cerebral Small Vessel Disease	30
Axonal Degeneration in AD: The Contribution of Aβ and Tau	30
Homocysteine and Folic Acid: Risk Factors for Alzheimer's Disease—An Updated Meta-Analysis	30
Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases	30
Administration of Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI Improves Cognitive and Memory Function in the Mouse Model of Alzheimer’s Disease	30
Vascular Dementia and Underlying Sex Differences	30
Mitochondria: Novel Mechanisms and Therapeutic Targets for Secondary Brain Injury After Intracerebral Hemorrhage	30
Increased Salivary microRNAs That Regulate DJ-1 Gene Expression as Potential Markers for Parkinson’s Disease	30
Functional MRI-Specific Alterations in Salience Network in Mild Cognitive Impairment: An ALE Meta-Analysis	29
Mitochondrial Dynamics: A Potential Therapeutic Target for Ischemic Stroke	29
Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation	29
Lactulose and Melibiose Attenuate MPTP-Induced Parkinson’s Disease in Mice by Inhibition of Oxidative Stress, Reduction of Neuroinflammation and Up-Regulation of Autophagy	29
Molecular Level Insight Into the Benefit of Myricetin and Dihydromyricetin Uptake in Patients With Alzheimer’s Diseases	29
The Influence of Demographics and Vascular Risk Factors on Glymphatic Function Measured by Diffusion Along Perivascular Space	28
Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease	28
Neuroprotective Roles of the Reverse Transsulfuration Pathway in Alzheimer’s Disease	28
Factors Associated With the Dilation of Perivascular Space in Healthy Elderly Subjects	28
Cerebral small vessel disease: Pathological mechanisms and potential therapeutic targets	28

Gut-Derived Metabolite Phenylacetylglutamine and White Matter Hyperintensities in Patients With Acute Ischemic Stroke	28
The Roles of Optogenetics and Technology in Neurobiology: A Review	28
Corticomotor Plasticity Predicts Clinical Efficacy of Combined Neuromodulation and Cognitive Training in Alzheimer’s Disease	28
The Emerging Role of Neuropeptides in Parkinson’s Disease	28
Alzheimer’s Disease Diagnosis and Biomarker Analysis Using Resting-State Functional MRI Functional Brain Network With Multi-Measures Features and Hippocampal Subfield and Amygdala Volume of Structural	28
A Comprehensive Phenotype of Non-motor Impairments and Distribution of Alpha-Synuclein Deposition in Parkinsonism-Induced Mice by a Combination Injection of MPTP and Probenecid	28
Transneuronal Degeneration in the Brain During Glaucoma	27
Brain Entropy Mapping in Healthy Aging and Alzheimer’s Disease	27
Exogenous Alpha-Synuclein Evoked Parkin Downregulation Promotes Mitochondrial Dysfunction in Neuronal Cells. Implications for Parkinson’s Disease Pathology	27
Age-Associated Neurological Complications of COVID-19: A Systematic Review and Meta-Analysis	27
Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models	27
Mean Apparent Propagator MRI Is Better Than Conventional Diffusion Tensor Imaging for the Evaluation of Parkinson’s Disease: A Prospective Pilot Study	27
The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases	27
Aberrant Amplitude of Low-Frequency Fluctuations in Different Frequency Bands in Patients With Parkinson’s Disease	27
A Large-Scale Open Motion Dataset (KFall) and Benchmark Algorithms for Detecting Pre-impact Fall of the Elderly Using Wearable Inertial Sensors	27
Role of Neuron and Glia in Alzheimer’s Disease and Associated Vascular Dysfunction	27
Neurovascular Alterations in Vascular Dementia: Emphasis on Risk Factors	27
Contributions of Hippocampal Volume to Cognition in Healthy Older Adults	26
The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis	26
Acupuncture for the Treatment of Alzheimer's Disease: An Overview of Systematic Reviews	26
Exercise-Induced Benefits for Alzheimer’s Disease by Stimulating Mitophagy and Improving Mitochondrial Function	26
Wearable Devices for Assessing Function in Alzheimer's Disease: A European Public Involvement Activity About the Features and Preferences of Patients and Caregivers	26
Predicting MCI to AD Conversation Using Integrated sMRI and rs-fMRI: Machine Learning and Graph Theory Approach	26
MicroRNAs as Potential Orchestrators of Alzheimer's Disease-Related Pathologies: Insights on Current Status and Future Possibilities	26
Potential Therapies for Cerebral Edema After Ischemic Stroke: A Mini Review	25
Application of Evans Index in Normal Pressure Hydrocephalus Patients: A Mini Review	25
Resveratrol Modulates the Gut-Brain Axis: Focus on Glucagon-Like Peptide-1, 5-HT, and Gut Microbiota	25
Impaired Learning and Memory Ability Induced by a Bilaterally Hippocampal Injection of Streptozotocin in Mice: Involved With the Adaptive Changes of Synaptic Plasticity	25
Hearing Loss and Dementia: A Meta-Analysis of Prospective Cohort Studies	25
Early Noise-Induced Hearing Loss Accelerates Presbycusis Altering Aging Processes in the Cochlea	25
Epigenetics in Alzheimer’s Disease	25
Classification and Graphical Analysis of Alzheimer’s Disease and Its Prodromal Stage Using Multimodal Features From Structural, Diffusion, and Functional Neuroimaging Data and the APOE Genotype	25
Regular Tai Chi Practice Is Associated With Improved Memory as Well as Structural and Functional Alterations of the Hippocampus in the Elderly	25
Evaluation of the Mini-Mental State Examination and the Montreal Cognitive Assessment for Predicting Post-stroke Cognitive Impairment During the Acute Phase in Chinese Minor Stroke Patients	25
Aged Microglia in Neurodegenerative Diseases: Microglia Lifespan and Culture Methods	25
The Potential of Ferroptosis-Targeting Therapies for Alzheimer’s Disease: From Mechanism to Transcriptomic Analysis	25
Altered Cholesterol Homeostasis in Huntington’s Disease	25
Enriched Environment Attenuates Pyroptosis to Improve Functional Recovery After Cerebral Ischemia/Reperfusion Injury	24
Regulation of Mitophagy by Sirtuin Family Proteins: A Vital Role in Aging and Age-Related Diseases	24
Stress Granules and Neurodegenerative Disorders: A Scoping Review	24
LncRNAs Stand as Potent Biomarkers and Therapeutic Targets for Stroke	24
A Shift in Tissue Stiffness During Hippocampal Maturation Correlates to the Pattern of Neurogenesis and Composition of the Extracellular Matrix	24
The Unfolded Protein Response in Immune Cells as an Emerging Regulator of Neuroinflammation	24
Convergent Functional Changes of Default Mode Network in Mild Cognitive Impairment Using Activation Likelihood Estimation	24
Neuroinflammation: A Possible Link Between Chronic Vascular Disorders and Neurodegenerative Diseases	24
Ketogenic diet prevents chronic sleep deprivation-induced Alzheimer’s disease by inhibiting iron dyshomeostasis and promoting repair via Sirt1/Nrf2 pathway	24
Prediction Models for Conversion From Mild Cognitive Impairment to Alzheimer’s Disease: A Systematic Review and Meta-Analysis	24
The role of brain derived neurotrophic factor in central nervous system	24
Relieving Cellular Energy Stress in Aging, Neurodegenerative, and Metabolic Diseases, SIRT1 as a Therapeutic and Promising Node	24
A Signature of Five Long Non-Coding RNAs for Predicting the Prognosis of Alzheimer's Disease Based on Competing Endogenous RNA Networks	24
Brain NAD Is Associated With ATP Energy Production and Membrane Phospholipid Turnover in Humans	24
Acupuncture-Related Therapies for Parkinson's Disease: A Meta-Analysis and Qualitative Review	24
Neuropsychological impairment in post-COVID condition individuals with and without cognitive complaints	24
Efficacy and Safety of Probiotics for the Treatment of Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease: A Systematic Review and Meta-Analysis	24
Network Pharmacology-Based and Experimental Identification of the Effects of Quercetin on Alzheimer’s Disease	24
The Human Body as a Super Network: Digital Methods to Analyze the Propagation of Aging	24
COVCOG 1: Factors Predicting Physical, Neurological and Cognitive Symptoms in Long COVID in a Community Sample. A First Publication From the COVID and Cognition Study	24
Epigenetics in depression and gut-brain axis: A molecular crosstalk	24
Sleep Disturbances in MCI and AD: Neuroinflammation as a Possible Mediating Pathway	23
Posterior Cingulate Cortex Network Predicts Alzheimer's Disease Progression	23
Niacin Enhancement for Parkinson’s Disease: An Effectiveness Trial	23
Deep Learning Model for Prediction of Progressive Mild Cognitive Impairment to Alzheimer’s Disease Using Structural MRI	23
Functional Disorganization of Small-World Brain Networks in Patients With Ischemic Leukoaraiosis	23
Individual Differences in Interoceptive Accuracy Are Correlated With Salience Network Connectivity in Older Adults	23
Memory and Learning Deficits Are Associated With Ca2+ Dyshomeostasis in Normal Aging	23
Cognitive Assessment in SARS-CoV-2 Patients: A Systematic Review	23
Insights Into the Role of CSF1R in the Central Nervous System and Neurological Disorders	23
Role of BDNF/ProBDNF Imbalance in Postoperative Cognitive Dysfunction by Modulating Synaptic Plasticity in Aged Mice	23
AChRs Degeneration at NMJ in Aging-Associated Sarcopenia–A Systematic Review	23
Gray Matter Deterioration Pattern During Alzheimer's Disease Progression: A Regions-of-Interest Based Surface Morphometry Study	23
Sleep in Older Adults and Its Possible Relations With COVID-19	23
Circulating Inflamma-miRs as Potential Biomarkers of Cognitive Impairment in Patients Affected by Alzheimer’s Disease	23
Interplay Between Microglia and Alzheimer’s Disease—Focus on the Most Relevant Risks: APOE Genotype, Sex and Age	23
Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP)	23
Delirium: A Marker of Vulnerability in Older People	23
Exploring the Key Genes and Identification of Potential Diagnosis Biomarkers in Alzheimer’s Disease Using Bioinformatics Analysis	23
Inflammation, Cognition, and White Matter in Older Adults: An Examination by Race	23
Altered Brain Function in Cerebral Small Vessel Disease Patients With Gait Disorders: A Resting-State Functional MRI Study	23
Extracellular Vesicles From 3xTg-AD Mouse and Alzheimer’s Disease Patient Astrocytes Impair Neuroglial and Vascular Components	23
Challenges and Limitations of Targeting the Keap1-Nrf2 Pathway for Neurotherapeutics: Bach1 De-Repression to the Rescue	23
Impaired Topographical Organization of Functional Brain Networks in Parkinson’s Disease Patients With Freezing of Gait	23
Metabolomic and Lipidomic Profiling of Preoperative CSF in Elderly Hip Fracture Patients With Postoperative Delirium	22
TDP-43 Is Elevated in Plasma Neuronal-Derived Exosomes of Patients With Alzheimer’s Disease	22
Repetitive Transcranial Magnetic Stimulation for Improving Cognitive Function in Patients With Mild Cognitive Impairment: A Systematic Review	22
Redox Post-translational Modifications of Protein Thiols in Brain Aging and Neurodegenerative Conditions—Focus on S-Nitrosation	22
Medial Temporal Lobe Subregional Atrophy in Aging and Alzheimer's Disease: A Longitudinal Study	22
Microvascular Changes in Parkinson’s Disease- Focus on the Neurovascular Unit	22
Active Life for Brain Health: A Narrative Review of the Mechanism Underlying the Protective Effects of Physical Activity on the Brain	22
The Role of Non-coding RNAs in Alzheimer’s Disease: From Regulated Mechanism to Therapeutic Targets and Diagnostic Biomarkers	22
Catecholamines in Alzheimer's Disease: A Systematic Review and Meta-Analysis	22
Dilated Perivascular Space in the Midbrain May Reflect Dopamine Neuronal Degeneration in Parkinson’s Disease	22
The Role of Microglia in Alzheimer’s Disease From the Perspective of Immune Inflammation and Iron Metabolism	22
Cognitive Reserve, Leisure Activity, and Neuropsychological Profile in the Early Stage of Cognitive Decline	22
Sex-Specific Cross Tissue Meta-Analysis Identifies Immune Dysregulation in Women With Alzheimer’s Disease	22
The Influence of Aging, Hearing, and Tinnitus on the Morphology of Cortical Gray Matter, Amygdala, and Hippocampus	22